89.12
BATS BZX Real-Time Price
As of 11:57am ET
 -0.21 / -0.24%
Today’s Change
62.48
Today|||52-Week Range
110.37
+2.06%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$19.8B

Company Description

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.

Contact Information

Incyte Corp.
1801 Augustine Cut-Off
Wilmington Delaware 19803
P:(302) 498-6700
Investor Relations:
(302) 498-5914

Employees

Shareholders

Mutual fund holders54.29%
Other institutional41.68%
Individual stakeholders18.21%

Top Executives

Hervé HoppenotChairman, President & Chief Executive Officer
Christiana StamoulisChief Financial Officer & Executive Vice President
Steven H. SteinChief Medical Officer & Executive Vice President
Dashyant DhanakChief Scientific Officer & Executive VP
Barry P. FlannellyExecutive Vice President & General Manager